Compatibilité physico-chimique du méthotrexate avec les médicaments co-administrés dans les protocoles de chimiothérapie = Physico-chemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimensAUJOULAT, P; COZE, C; BRAGUER, D et al.Journal de pharmacie clinique (Paris). 1993, Vol 12, Num 1, pp 31-35, issn 0291-1981Article

Autogreffes de moelle osseuse et cancer pédiatriques : Cancers de l'enfant = Autologous bone marrow transplantation in childhood cancersGENTET, J. C; PLOUVIER, E; COZE, C et al.La Revue du praticien (Paris). 1993, Vol 43, Num 17, pp 2213-2217, issn 0035-2640Article

Prise en charge de la douleur de l'enfant atteint de cancer en Afrique: état des lieux au sein du Groupe franco-africain d'oncologie pédiatrique = Managing pain in children with cancer in Africa: A survey from the French-African Pediatric Oncology groupYAO, A; COZE, C; HARIF, M et al.Archives de pédiatrie (Paris). 2013, Vol 20, Num 3, pp 257-264, issn 0929-693X, 8 p.Article

Lymphome non-Hodgkinien de l'enfant : prise en charge chirurgicale lors d'un tableau abdominal révélateur : Recommandations du « Comité lymphome » de la Société française de lutte contre les cancers de l'enfant et de l'adolescent (SFCE) = Pediatric non-Hodgkin's lymphoma : primary surgical management of patients presenting with abdominal symptoms. Recommendations of the Lymphoma Committee of the French Society to Combat Pediatric Cancers (SFCE)DELARUE, A; BERGERON, C; MECHINAUD-LACROIX, F et al.Journal de chirurgie (Paris. 1908). 2008, Vol 145, Num 5, pp 454-458, issn 0021-7697, 5 p.Article

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (Filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastomaMICHON, J. M; HARTMANN, O; LEMERLE, J et al.European journal of cancer (1990). 1998, Vol 34, Num 7, pp 1063-1069, issn 0959-8049Article

Pneumoblastome chez l'enfant. Cas clinique et revue de la littérature = Pulmonary blastoma in children. Case report and review of literatureBONGO, S; COZE, C; SCHEINER, C et al.Bulletin du cancer. 1996, Vol 83, Num 10, pp 877-881, issn 0007-4551Article

Déficit immunitaire et cancer = Immunodeficiency and cancerFAVROT, M. C; PHILIP, T; COZE, C et al.Pédiatrie (Marseille). 1989, Vol 44, Num 1, pp 11-18, issn 0031-4021Article

Glossary of cytokinesCOZE, C. M.Baillière's clinical haematology. 1994, Vol 7, Num 1, pp 1-15, issn 0950-3536Article

Syndrome opsoclonus-myoclonus associé au neuroblastome non métastatique. Suivi à long terme. Etude de la Société française d'oncologie pédiatrique = Long-term outcome in children with opsoclonus-myoclonus associated with localized neuroblastoma : a report from the french society of pediatric oncologyPLANTAZ, D; MICHON, J; ARMARI-ALLA, C et al.Archives de pédiatrie (Paris). 2000, Vol 7, Num 6, pp 621-628, issn 0929-693XConference Paper

Evaluation of micronucleated lymphocytes, constitutional karyotypes and anti-p53 antibodies in 21 children with various malignanciesFELLAY-REYNIER, I; ORSIERE, T; SARI-MINODIER, I et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2000, Vol 467, Num 1, pp 31-39, issn 1383-5718Article

Localized childhood Hodgkin's disease : Response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90LANDMAN-PARKER, J; PACQUEMENT, H; DONADIEU, J et al.Journal of clinical oncology. 2000, Vol 18, Num 7, pp 1500-1507, issn 0732-183XArticle

NB87 induction protocol for stage 4 Neuroblastoma in children over 1 year of age : A report from the French Society of Pediatric OncologyCOZE, C; HARTMANN, O; BECK, D et al.Journal of clinical oncology. 1997, Vol 15, Num 12, pp 3433-3440, issn 0732-183XArticle

La tumeur d'Ewing : connaissances et méconnaissances actuelles = Ewing's tumor: current knowledge and misconceptionsGENTET, J. C; PANUEL, M; SHEINER, C et al.Pédiatrie (Marseille). 1992, Vol 47, Num 12, pp 799-807, issn 0031-4021Article

The impact of megatherapy on response and survival in high-risk Ewing's sarcoma. A report of the EBMT solid tumor registryLADENSTEIN, R; LASSET, C; HARTMANN, O et al.Bone marrow transplantation. Supplement (Basingstoke). 1992, Vol 10, Num 2, issn 0951-3078, p. 20Conference Paper

Stratégie de prise en charge de contages tuberculeux dans un service d'oncologie-pédiatrique = Evaluation of a screening strategy after occurence of two simultaneous contaminating tuberculosis cases in a pediatric oncology departmentGAUCHON, A; ANDRE, N; ROME, A et al.Archives de pédiatrie (Paris). 2008, Vol 15, Num 3, pp 236-244, issn 0929-693X, 9 p.Article

Autogreffes de cellules souches hématopoïétiques en oncologie pédiatrique ; étude des complications infectieuses survenant au cours de la première année après sortie d'aplasie = Infectious complications postengrafment in the first year after autologous stem cell transplantation in childrenBEN SALAH, H; COZE, C; GENTET, J. C et al.Archives de pédiatrie (Paris). 2005, Vol 12, Num 5, pp 526-532, issn 0929-693X, 7 p.Article

Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapyRUBIE, H; COZE, C; MOSSERI, V et al.British journal of cancer. 2003, Vol 89, Num 9, pp 1605-1609, issn 0007-0920, 5 p.Article

The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over I year at diagnosisFRAPPAZ, D; PEROL, D; MICHON, J et al.British journal of cancer. 2002, Vol 87, Num 11, pp 1197-1203, issn 0007-0920, 7 p.Article

A lack of neuroblastoma in Down syndrome : A study from 11 European countriesSATGE, D; SASCO, A. J; LANGMARK, F et al.Cancer research (Baltimore). 1998, Vol 58, Num 3, pp 448-452, issn 0008-5472Article

Neuroblastomes localisés : facteurs de pronostic et traitements actuels = Localized neuroblastomas : prognostic factors and current therapyRUBIE, H; MICHON, J; PLANTAZ, D et al.Pathologie et biologie. 1994, Vol 42, Num 10, pp 1033-1034, issn 0369-8114Conference Paper

Indications des chimiothérapies lourdes avec autogreffe de moelle en oncologie pédiatriqueCOZE, C; GENTET, J.-C; BERNARD, J.-L et al.La Médecine infantile (Paris). 1991, Vol 98, Num 5, pp 373-380, issn 0025-6773Article

Severe acute toxicity associated with high-dose methotrexate (MTX) therapy : use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuationESTEVE, M.-A; DEVICTOR-PIERRE, B; GALY, G et al.European journal of clinical pharmacology. 2007, Vol 63, Num 1, pp 39-42, issn 0031-6970, 4 p.Article

Le pronostic du neuroblastome de l'enfant. méthodes d'étude et utilisation en pratique clinique = Prognosis of neuroblastoma in childhood. Methods of assessment and clinical usePEREL, Y; VALTEAU-COUANET, D; THOMAS, C et al.Archives de pédiatrie (Paris). 2004, Vol 11, Num 7, pp 834-842, issn 0929-693X, 9 p.Article

Congenital disseminated malignant rhabdoid tumor and cerebellar tumor mimicking medulloblastoma in monozygotic twins: Pathologic and molecular diagnosisFERNANDEZ, C; BOUVIER, C; SEVENET, N et al.The American journal of surgical pathology. 2002, Vol 26, Num 2, pp 266-270, issn 0147-5185Article

Chimiothérapie intensive des rechutes du médulloblastome du jeune enfant = High-dose chemotherapy followed by autologous bone marrow transplantation in relapse of medulloblastomaDUPUIS-GIROD, S; HARTMANN, O; BENHAMOU, E et al.Bulletin du cancer. 1997, Vol 84, Num 3, pp 264-272, issn 0007-4551Article